Nanofiber-based systems intended for diabetes

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Endocrinology

Background:

• Diabetic mellitus (DM) is a prevalent metabolic disorder characterized by insulin deficiency and hyperglycemia, leading to severe complications like organ failure and amputations.
• The progressive destruction of pancreatic β cells underlies DM pathogenesis, necessitating innovative therapeutic strategies.
• Current treatments often fail to fully address the multifaceted complications of DM.

Purpose of the Study:

• To explore the potential of nanofiber (NF)-based delivery systems for managing diabetic mellitus complications.
• To discuss the application of NF scaffolds in delivering therapeutic agents and supporting cell therapy for DM.
• To highlight the role of NF systems in tissue regeneration, particularly for diabetic skin ulcers.

Main Methods:

• Fabrication of NF-based systems using natural, synthetic, or composite materials.
• Incorporation of therapeutic agents (e.g., insulin) and cells into NF scaffolds.
• Evaluation of NF systems for their capacity to deliver macromolecules and small molecules.
• Assessment of NF scaffolds as microenvironments for pancreatic β cell transplantation and tissue engineering.

Main Results:

• NF systems can effectively deliver both macromolecules like insulin and small molecules.
• NF scaffolds provide a suitable microenvironment for pancreatic β cell transplantation and tissue engineering.
• Therapeutics/cells-incorporated NF mats demonstrate potential in promoting proliferation, regeneration, and remodeling of diabetic skin ulcers.

Conclusions:

• Nanofiber-based systems represent a significant advancement in addressing diabetic mellitus complications.
• These systems offer versatile applications in drug delivery, cell therapy, and tissue regeneration for DM patients.
• Further research into NF systems holds promise for developing novel treatments to obviate DM-related disorders.